Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction
Autor: | Grant T. Baldwin, Alana M. Vivolo-Kantor, Christopher M. Jones, Debra Houry, Wilson M. Compton, Beth Han |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment media_common.quotation_subject General Biochemistry Genetics and Molecular Biology Article Methamphetamine History and Philosophy of Science Harm Reduction Epidemiology medicine Humans Opioid Epidemic Psychiatry media_common Harm reduction business.industry Illicit Drugs General Neuroscience Addiction Opioid overdose medicine.disease Mental health United States Stimulant Opioid Drug Overdose business medicine.drug |
Zdroj: | Ann N Y Acad Sci |
ISSN: | 1749-6632 |
Popis: | Recent attention has focused on the growing role of psychostimulants, such as methamphetamine in overdose deaths. Methamphetamine is an addictive and potent stimulant, and its use is associated with a range of physical and mental health harms, overdose, and mortality. Adding to the complexity of this resurgent methamphetamine threat is the reality that the increases in methamphetamine availability and harms are occurring in the midst of and intertwined with the ongoing opioid overdose crisis. Opioid involvement in psychostimulant-involved overdose deaths increased from 34.5% of overdose deaths in 2010 to 53.5% in 2019-an increase of more than 50%. This latest evolution of the nation's overdose epidemic poses novel challenges for prevention, treatment, and harm reduction. This narrative review synthesizes what is known about changing patterns of methamphetamine use with and without opioids in the United States, other characteristics associated with methamphetamine use, the contributions of the changing illicit drug supply to use patterns and overdose risk, motivations for couse of methamphetamine and opioids, and awareness of exposure to opioids via the illicit methamphetamine supply. Finally, the review summarizes illustrative community and health system strategies and research opportunities to advance prevention, treatment, and harm reduction policies, programs, and practices. |
Databáze: | OpenAIRE |
Externí odkaz: |